Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Accounts Payables (2020 - 2025)

Agilon Health (AGL) has disclosed Accounts Payables for 6 consecutive years, with $127.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 42.15% year-over-year to $127.5 million, compared with a TTM value of $127.5 million through Dec 2025, down 42.15%, and an annual FY2025 reading of $127.5 million, down 42.15% over the prior year.
  • Accounts Payables was $127.5 million for Q4 2025 at Agilon Health, down from $145.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $257.8 million in Q2 2023 and bottomed at $95.1 million in Q1 2021.
  • Average Accounts Payables over 5 years is $166.1 million, with a median of $145.5 million recorded in 2025.
  • The sharpest move saw Accounts Payables surged 81.5% in 2023, then crashed 42.15% in 2025.
  • Year by year, Accounts Payables stood at $112.9 million in 2021, then surged by 57.09% to $177.4 million in 2022, then soared by 34.95% to $239.4 million in 2023, then decreased by 7.97% to $220.3 million in 2024, then plummeted by 42.15% to $127.5 million in 2025.
  • Business Quant data shows Accounts Payables for AGL at $127.5 million in Q4 2025, $145.5 million in Q3 2025, and $220.3 million in Q4 2024.